Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients

Transplant Immunology

Volumn 5, Issue 2, 1997, Pages 104-111

  Toyoda, Mieko ^a   Galfayan, Karine ^a   Galera, Odette A ^a   Petrosian, Anna ^a   Czer, Lawrence S C ^a   Jordan, Stanley C ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2;

ARTICLE; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT;

EID: 0030738950     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(97)80050-0     Document Type: Article

References (39)

1. Richardson WP, Colvin RB, Cheesman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB et al. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 1981; 305: 57-63.
2. Puoteil-Noble C, Ecochard R, Landrivon G, Donia-Maged A, Tardy JC, Bosshard S et al. Cytomegalovirus infection - an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 1993; 55: 851-57.
3. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J Am Med Assoc 1989; 261: 3561-66.
4. Kendall TJ, Wilson JE, Radio SJ, Kandolf R, Gulizia JM, Winters GL et al. Cytomegalovirus and other herpes viruses: Do they have a role in the development of accelerated coronary arterial disease in human heart allografts? J Heart Lung Transplant 1992; 11: S14-20.
5. Van Dam-Mieras MCE, Muller AD, Van Hinsbergh VWM, Mullers WJHA, Bomans PHH, Bruggeman CA. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 1992; 68: 364-70.
6. Span AHM, van Boven CPA, Bruggeman CA. The effect of cytomegalovirus infection on the adherence of polymorphonuclear leukocytes to endothelial cells. Eur J Clin Invest 1989; 19: 542-48.
7. Span AHM, Endert J, Van Boven CPA, Bruggeman CA. Virus induced adherence of monocytes to endothelial cells. FEMS Microbiol Immunol 1989; 1: 237-44.
8. Tuder RM, Weinberg A, Panajotopoulos N, Kalil J. Cytomegalovirus enhances PBMC binding and HLA class I expression on cultured endothelial cells. Transplant Proc 1991; 23: 91-92.
9. Cotran RS, Pober JS. Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J Am Soc Nephrol 1990; 1: 225.
10. Van Dorp WT, Jonges E, Bruggeman CA, Daha MR, van Es LA, van der Woude FJ. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation 1989; 48: 469-72.
11. Von Willebrand E, Pettersson E, Ahonen J, Hayry P. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986; 42: 364-67.
12. Browne H, Smith G, Beck S, Minson T. A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin. Nature 1990; 347: 770-72.
13. Rose ML: Antibody-mediated rejection following cardiac transplantation. Transplant Rev 1993; 7: 140-52.
14. Jordan SC, Yap HK, Sakai RS, Alfonso P, Fitchman M. Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with a negative monocyte crossmatch. Transplantation 1988; 46: 585-87.
15. Yard B, Spruyt-Gerritse M, Claas F, Thorogood J, Bruijn JA, Paape ME et al. The clinical significance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation. Transplantation 1993; 55: 1287-93.
16. Paul LC, Claas FHJ, van Es LA, Kalff MW, de Graeff J. Accelerated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens on endothelium and monocytes. N Engl J Med 1979; 300: 1258-60.
17. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH. Antiendothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 1992; 339: 1566-70.
18. Toyoda M, Zhang XM, Sun Z, Czer L, Trento A, Jordan SC. Use of polymerase chain reaction to rapidly detect cytomegalovirus DNA in peripheral blood leukocytes of transplant recipients. Transplant Proc 1995; 27: 1272-73.
19. Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and interleukin-2 receptor genes. Am J Respir Cell Mol Biol 1991; 5: 292-96.
20. Liebson HJ, Marrack P, Kappler J. B cell helper factors. II. Synergy among three helper factors in the response of T cell- and macrophage-depleted B cells. J Immunol 1982; 129: 1398-402.
21. Jiwa NM, Van Gemert GW, Raap AK et al. Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction. Transplantation 1989; 48: 72-76.
22. Lubin MB, Elashoff JD, Wang SJ, Rotter JI, Toyoda H. Precise gene dosage determination by polymerase chain reaction: theory, methodology, and statistical approach. Molec Cell Probes 1991; 5: 307-17.
23. Rappaport VJ, Hirata G, Yap HK, Jordan SC. Anti-vascular endothelial cell antibodies in severe preeclampsia. Am J Obstet Gynecol 1990; 162: 138-46.
24. Payne JE, Fiala M, Spencer M, Chatterjee SN, Berne TV. Cytomegalovirus antigen-antibody complexes in biopsy specimens in renal allograft rejection. Surg Forum 1974; 25: 273-75.
25. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987; 2: 291-93.
26. Koyyana R, Toyoda M, Wachs K, Trento A, Czer L, Fishbein M et al. Significance of antibodies to human vascular endothelial cells in cardiac allograft recipients. Transplantation 1997 (in press).
27. Toyoda M, Galfayan K, Wachs K, Czer L, Jordan SC. Immunologic monitoring of OKT3 induction therapy in cardiac allograft recipients. Clin Transplant 1995; 9: 472-80.
28. Hricik D, Mayes JT, Schulak JA. Inhibition of anti-OKT3 antibody generation by cyclosporine - results of a prospective randomized trial. Transplantation 1990; 50: 237-40.
29. Wheeler CH, Collins A, Dunn MJ, Crisp SJ, Yacoub MH, Rose ML. Characterization of endothelial antigens associated with transplant-associated coronary artery disease. J Heart Lung Transplant 1995; 14: S188-97.
30. Iwamoto GK, Monick MM, Clark BD, Auron PE, Stinski MF, Hunninghake GW. Modulation of interleukin-1β gene expression by the immediate early genes of human cytomegalovirus. J Clin Invest 1990; 85: 1853-57.
31. Biron CA. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunology 1994; 6: 530-38.
32. Sedmak DD, Orosz CG. The role of vascular endothelial cells in transplantation. Arch Pathol Lab Med 1991; 115: 260-65.
33. Gehrz RC. Human cytomegalovirus: Biology and clinical perspectives. Adv Pediatr 1991; 38: 203-32.
34. Beck S, Barrell BC. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 1988; 331: 269-72.
35. Fujinami RS, Nelson JA, Walker L, Oldstone MBA. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta-chain: a means for graft rejection and immunosuppression. J Virol 1988; 62: 100-105.
36. Neote K, Digregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993; 72: 415-25.
37. Mouthon L, Haury M, Lacroix-Desmazes S, Barreau C, Coutinho A, Kazatchkine MD. Analysis of the normal human IgG antibody repertoire: evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues. J Immunol 1995; 154: 5769-78.
38. Ronda N, Haury M, Nobrega A, Kaveri SV, Coutinho A, Kazatchkine MD. Analysis of natural and disease-associated autoantibody repertoire: Anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int Immunol 1994; 6: 1651-60.
39. Ahmed R, Oldstone MBA. Mechanisms and biological implications of virus-induced polyclonal B-cell activation. In: Notkins AL, Oldstone MBA eds. Concepts in viral pathogenesis. New York: Springer-Verlag, 1984: 231-38.